ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Confidently compliant? Considerations for industry players to meet the new EMA guideline
Vesta Marciulioniene, Director, Global Regulatory Clinical Services and Jo Hulbert, Executive Director, Global Regulatory Clinical Services provide an overview of the EMA’s new framework on computerised systems and electronic data in clinical trials in this article from XTalks Clinical Edge.
Dublin-headquartered Icon plc reports double-digit third quarter profit growth
This article from the Business Post reports that Icon plc has reported double-digit profit growth for the third quarter of 2023.
ICON releases Q3 financial results
CFO Brendan Brennan is interviewed by Emmet Oliver on Newstalk’s Breakfast Business.
The Pharma Letter Podcast: CRO sector surges in bio revolution
This episode of The Pharma Letter Podcast features an interview with ICON’s Chief Commercial Officer, George McMillan.
Report from Global Site Solutions Summit October 2023
In this article in Contract Pharma provides an overview of the discussion on the recent Global Site Solutions Summit.
Outsourcing Model Usage and its Relationship to Clinical Trial Performance
Recent ICON plc collaboration with Tufts CSDD on a pilot study to validate new and more granular outsourcing model classifications
Automation in Clinical Trials
This article will explore how clinical trials have become more complex with more moving parts, along with the requirements for technology specific automation.
Navigating the data-rich landscape of healthcare: The utility of data exploration and visualisation
In the ever-expanding universe of real world data, exploration and visualization strategies have become indispensable. This article presents 5 takeaways relevant to these strategies.
Narratives for a clinical study report: The evolution of automation and artificial intelligence
In this article, find out what the future holds for narrative production in clinical studies now that we are in the era of AI.
Keeping eCOAs off the critical path – key considerations
How an optimised eCOA implementation strategy can minimise several risks and challenges associated with clinical trials.